161 QuantiGene 2.0® assay for measurement of ER and PR in breast cancer von Chae, B.J, Paik, J.M, Seo, Y.J, Park, W.C, Song, B.J, Kim, J.S, Oh, S.J, Jung, S.S, Lee, A, Park, S

Volltext

Safety of sodium-glucose cotransporter-2 inhibitors in patients with CKD and type 2 diabetes: population-based US cohort study von Fu, E.L., D'Andrea, E., Wexler, D.J., Patorno, E., Paik, J.M.

Volltext bestellen

Accuracy of GFR estimating equations in patients with discordances between creatinine and cystatin C-based estimations von Fu, E.L., Levey, A.S., Coresh, J., Elinder, C.G., Rotmans, J.I., Dekker, F.W., Paik, J.M., Barany, P., Grams, M.E., Inker, L.A., Carrero, J.J.

Volltext bestellen

Supplementary Material for: Medication Burden and Prescribing Patterns in Patients on Hemodialysis in the USA, 2013–2017 von J.M., Paik, M., Zhuo, C., York, T., Tsacogianis, S.C., Kim, R.J., Desai

Volltext bestellen

Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb tri... von Moehler, M., Heo, J., Lee, H.C., Tak, W.Y., Chao, Y., Paik, S.W., Yim, H.J., Byun, K.S., Baron, A., Ungerechts, G., Jonker, D., Ruo, L., Cho, M., Kaubisch, A., Wege, H., Merle, P., Ebert, O., Habersetzer, F., Blanc, J.F., Rosmorduc, Olivier, Lencioni, R., Patt, R., Leen, A.M., Foerster, F., Homerin, M., Stojkowitz, N., Lusky, M., Limacher, J.M., Hennequi, M., Gaspar, N., McFadden, B., De Silva, N., Shen, D., Pelusio, A., Kirn, D.H., Breitbach, C.J., Burke, J.M.

Volltext

Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration von Bossuyt, V., Provenzano, E., Symmans, W.F., Boughey, J.C., Coles, C., Curigliano, G., Dixon, J.M., Esserman, L.J., Fastner, G., Kuehn, T., Peintinger, F., von Minckwitz, G., White, J., Yang, W., Badve, S., Denkert, C., MacGrogan, G., Penault-Llorca, F., Viale, G., Cameron, D., Earl, Helena, Alba, Emilio, Lluch, Ana, Albanell, Joan, Amos, Keith, Biernat, Wojciech, Bonnefoi, Hervé, Buzdar, Aman, Cane, Paul, Pinder, Sarah, Carson, Lesley, Dickson-Witmer, Diana, Gong, Gyungyub, Green, Jimmy, Hsu, Chih-Yi, Tseng, Ling-Ming, Kroep, Judith, Leitch, A. Marilyn, Sarode, Venetia, Mamounas, Eleftherios, Marcom, Paul Kelly, Nuciforo, Paolo, Paik, Soonmyung, Peg, Vicente, Peston, David, Pierga, Jean-Yves, Quintela-Fandino, Miguel, Salgado, Roberto, Sikov, William, Thomas, Jeremy, Unzeitig, Gary, Wesseling, Jelle

Volltext

Expanded Criteria for Liver Transplantation in Patients with Hepatocellular Carcinoma von Kim, J.M, Kwon, C.H.D, Joh, J.-W, Park, J.B, Lee, J.H, Kim, G.S, Kim, S.J, Paik, S.W, Lee, S.-K

Volltext

macroH2A2 antagonizes epigenetic programs of stemness in glioblastoma von Nikolic, Ana, Maule, Francesca, Bobyn, Anna, Ellestad, Katrina, Paik, Seungil, Marhon, Sajid A., Mehdipour, Parinaz, Lun, Xueqing, Chen, Huey-Miin, Mallard, Claire, Hay, Alexander J., Johnston, Michael J., Gafuik, Christopher J., Zemp, Franz J., Shen, Yaoqing, Ninkovic, Nicoletta, Osz, Katalin, Labit, Elodie, Berger, N. Daniel, Brownsey, Duncan K., Kelly, John J., Biernaskie, Jeff, Dirks, Peter B., Derksen, Darren J., Jones, Steven J. M., Senger, Donna L., Chan, Jennifer A., Mahoney, Douglas J., De Carvalho, Daniel D., Gallo, Marco

Volltext

THU-165 - Comparision of long-term outcome for single small hepatocellular carcinoma between different treatment modalities by size and tumor marker von Sinn, D.H., Lee, S.-G., Hyun, D., Shin, S.W., Choi, G.-S., Kim, J.M., Kang, T.W., Lee, M.W., Kang, W., Gwak, G.-Y., Paik, Y.-H., Choi, M.S., Lee, J.H., Koh, K.C., Paik, S.W., Yoo, B.C.

Volltext

Comparision of long-term outcome for single small hepatocellular carcinoma between different treatment modalities by size and tumor marker von Sinn, D.H., Lee, S.-G., Hyun, D., Shin, S.W., Choi, G.-S., Kim, J.M., Kang, T.W., Lee, M.W., Kang, W., Gwak, G.-Y., Paik, Y.-H., Choi, M.S., Lee, J.H., Koh, K.C., Paik, S.W., Yoo, B.C.

Volltext

Acquisition of Carbapenemase-Producing Enterobacteriaceae in Solid Organ Transplantation Recipients von Lee, K.H., Han, S.H., Yong, D., Paik, H.C., Lee, J.G., Kim, M.S., Joo, D.J., Choi, J.S., Kim, S.I., Kim, Y.S., Park, M.S., Kim, S.Y., Yoon, Y.N., Kang, S., Jeong, S.J., Choi, J.Y., Song, Y.G., Kim, J.M.

Volltext

MA13.08 A Phase 1 Trial of Sapanisertib and Telaglenastat (CB-839) in Patients with Advanced NSCLC (NCI 10327): Results from Dose Escalation von Riess, J., Frankel, P., Massarelli, E., Nieva, J., Lai, W.-C.V., Koczywas, M., Shackelford, D., Lanza, I., Reid, J.M., Gonsalves, W.I., Remick, A.J., Gandara, D.R., Piekarz, R., Lara, P.N., Newman, E., Villalona-Calero, M., Paik, P.

Volltext

Effectiveness of Locoregional Therapy Before Living Donor Liver Transplantation in Patients With Hepatocellular Carcinoma Who Meet the Milan Criteria von Kim, J.M, Kwon, C.H.D, Joh, J.-W, Choi, M.S, Lee, J.H, Koh, K.C, Paik, S.W, Kim, G.S, Kim, S.J, Lee, S.-K, Yoo, B.C

Volltext

Surgical resection is considered in resectable solitary hepatocellular carcinoma with portal vein tumor thrombosis of patients with Child A von Kim, J.M., Kwon, C.H.D., Joh, J.-W., Choi, G.-S., Sinn, D.H., Paik, Y.-H., Lee, J.H.

Volltext

THU-167 - Surgical resection is considered in resectable solitary hepatocellular carcinoma with portal vein tumor thrombosis of patients with Child A von Kim, J.M., Kwon, C.H.D., Joh, J.-W., Choi, G.-S., Sinn, D.H., Paik, Y.-H., Lee, J.H.

Volltext

A HUPO test sample study reveals common problems in mass spectrometry-based proteomics von Bergeron, John J M, Bell, Alexander W, Deutsch, Eric W, Au, Catherine E, Kearney, Robert E, Beavis, Ron, Sechi, Salvatore, Nilsson, Tommy

Volltext

Predictive factors for nonsentinel lymph node metastasis in patients with positive sentinel lymph nodes after neoadjuvant chemotherapy von Ryu, J.M., Nam, S.J., Lee, J.E., Yu, J., Lee, S.K., Bae, S.Y., Paik, H.-J., Park, S.

Volltext

P963 SINGLE HCC ≤3cm IN LEFT LATERAL SEGMENT: LIVER RESECTION OR RADIOFREQUENCY ABLATION? von Kim, J.M, Kang, T.W, Choi, J.Y, Lee, S, Cho, W, Kwon, C.H.D, Rhim, H, Lee, J.H, Paik, S.W, Joh, J.-W

Volltext

Multicenter, nonrandomized, open-label Phase 1b study of FP-1039/GSK3052230 with chemotherapy: results in malignant pleural mesothelioma (MPM) von Trigo Perez, J.M., van Brummelen, E., Levchenko, E., Domine Gomez, M., Fennell, D.A., Kindler, H.L., Viteri, S., Gadgeel, S., Garrido Lopez, P., Kostorov, V., Morgensztern, D., Orlov, S., Paik, P.K., Vansteenkiste, J.F., Wang, X., Sharabidze, A., Deyoung, M.P., Baker, K.P., Yan, L., Mitrica, I.

Volltext

1220TiPMULTI-ARM, NONRANDOMIZED, OPEN-LABEL PHASE IB STUDY TO EVALUATE FP1039/GSK3052230 WITH CHEMOTHERAPY IN NSCLC AND MPM WITH DEREGULATED FGF PATHWAY SIGNALING von Garrido, P., Felip, E., Delord, J.P., Paz-Ares, L., Barlesi, F., Arkenau, H., Lara, P., Paik, P.K., Morgensztern, D., Gadgeel, S., Reckamp, K., Bertino, E., Orlov, S., Levchenko, E., Delgado, I., Trigo, J.M., Viteri, S., Vansteenkiste, J.F., Kindler, H., Lassen, U.N.

Volltext